Evidence-based approach to funding choices more important than ever

+Opinion

Evidence-based approach to funding choices more important than ever

Guest Writer

Guest Writer

Pharmac chief executive Sarah Fitt
Pharmac executive Sarah Fitt

Cancer will affect almost all New Zealanders at some point in their lives. Given the range of new treatments in the pipeline, PHARMAC works hard to fund the best medicines it can based on the evidence, says Sarah Fitt, chief executive.

We all know someone who is, or might be, affected by some form of illness. PHARMAC recognises this is a significant issue for many people, and is a